<DOC>
	<DOCNO>NCT01355354</DOCNO>
	<brief_summary>The purpose study investigate drug interaction fostamatinib digoxin compare safety , tolerability plasma concentration digoxin administer alone fostamatinib healthy subject .</brief_summary>
	<brief_title>Effects Administration Fostamatinib Blood Concentrations Digoxin Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Male female subject age 18 45 year ( inclusive ) Minimum weight 50 kg body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) Female subject must negative pregnancy test screen Day 1 , must lactate , must nonchildbearing potential History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug ( except cholecystectomy ) Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product Subjects smoke 5 cigarette equivalent tobacco per day Absolute neutrophil count &lt; 2500/mm3 2.5 x 109/L Previous treatment fostamatinib digoxin present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>RA , Fostamatinib</keyword>
	<keyword>Digoxin , drug-drug interaction</keyword>
	<keyword>Scientific terminology : Rheumatoid arthritis</keyword>
	<keyword>Fostamatinib</keyword>
	<keyword>Digoxin</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>Laymen terminology : Rheumatoid arthritis</keyword>
	<keyword>Amount Digoxin blood</keyword>
</DOC>